AGNP Board Exam with Answers – Men’s Health Prescription

$35.00

Category: Tag:

Description

AGNP BOARD EXAM – Men’s Health Prescription (53 Questions and Answers)

  1. Levofloxacin (Levaquin), used to treat acute bacterial prostatitis, is a:
  2. Ciprofloxacin, used for the treatment of bacterial prostatitis, is a potent CYP1A2 inhibitor and is absolutely contraindicated with other CYP1A2 inhibitors. An example of another CYP1A2 inhibitor is:
  3. A 33-year-old man has been taking sulfamethoxazole/trimethoprim for the treatment of bacterial prostatitis. Brand names of this medication do NOT include:
  4. Patients with uncomplicated acute bacterial prostatitis who are NOT good candidates for treatment with a fluoroquinolone should take:
  5. PDE-5 inhibitors, such as tadalafil (Cialis) for the treatment of erectile dysfunction, should be avoided in patients with:
  6. The choice for initial treatment of acute bacterial prostatitis is:
  7. Patients who take sildenafil (Viagra) for the treatment of erectile dysfunction, should be instructed to avoid:
  8. To help with symptoms of chronic prostatitis, in addition to antibiotics, consider adjunctive therapy with an:
  9. Patients taking vardenafil (Levitra) should be advised to immediately report:
  10. Initial and routine monitoring for patients with benign prostatic hyperplasia (BPH) who are receiving tamsulosin (Flomax) should include:
  11. The recommended pharmacological treatment for phimosis in an adult man is a(n):
  12. Doxycycline (Doryx) is LEAST effective in the treatment of:
  13. PDE-5 inhibitors, such as vardenafil (Levitra), are indicate in the treatment of:
  14. Concomitant administration of sildenafil (Viagra) should be avoide with:
  15. A 65-year-old man who is receiving finasteride (Proscar) for benign prostatic hyperplasia (BPH) is exhibiting progressive symptoms. To reduce these symptoms, prescribe:
  16. 5-alpha reductase inhibitors are use in the treatment of:
  17. The recommend treatment for uncomplicated acute bacterial prostatitis caused by Neisseria gonorrhea is:
  18. A 20-year-old man with phimosis should be instructed to apply betamethasone (Sernivo) 0.05% cream at least twice daily for:
  19. Doxycycline (Doryx) is classified as a:
  20. A 58-year-old man is receiving dutasteride (Avodart) for benign prostatic hyperplasia (BPH). Avodart, a 5-alpha reductase inhibitor:
  21. Initial treatment of acute prostatitis should be guided by urinalysis and culture, and antibiotic therapy should be given for at least:
  22. Which of the follow is NOT a fluoroquinolone use to treat prostatitis?
  23. Fluoroquinolones use to treat prostatitis are NOT effective against:
  24. Patients who are on prolonged fluoroquinolones (i.e. ciprofloxacin) for the treatment of chronic prostatitis should be advise to immediately report:
  25. Sulfamethoxazole and trimethoprim (Bactrim), for the treatment of acute bacterial prostatitis, should NOT be prescribe for patients with:
  26. Ciprofloxacin (Cipro) is a broad spectrum:
  27. Due to the risk of severe hypotension, patients who are taking sildenafil (Viagra) should be advise to avoid:
  28. A 27-year-old man is be treat for epididymitis with doxycycline (Doryx). The patient should be advise that doxycycline may cause:
  29. Empiric antibiotic treatment of epididymitis in a 68-year-old man is:
  30. Finasteride (Proscar) is an:
  31. In the treatment of prostatitis, antibiotics that do NOT penetrate well into the prostate and seminal fluids include:
  32. A 60-year-old man who is treat with tamsulosin (Flomax) for benign prostatic hyperplasia (BPH) should NOT be treat concomitantly with:
  33. Which of the follow is a PDE-5 inhibitor indicate in the treatment of erectile dysfunction and benign prostatic hypertrophy?
  34. PDE-5 inhibitors, such as tadalafil (Cialis) for the treatment of erectile dysfunction, should be use with caution in patients who have:
  35. A 57-year-old man has chronic prostatitis with a causative organism that is resistant to fluoroquinolones. The patient has an allergy to sulfa drugs. The next best treatment option is:
  36. To avoid reducing the effectiveness of doxycycline (Doryx) for the treatment of epididymitis, it should not be taken concomitantly with:
  37. Patients receiving 5-alpha-reductase inhibitors should see maximum efficacy at approximately:
  38. A 65-year-old man with benign prostatic hyperplasia (BPH) is treat with tamsulosin (Flomax). Potential side effects are:
  39. A 55-year-old man with benign prostatic hypertrophy has overflow incontinence. The first-line treatment is:
  40. Suppressive antibiotic therapy for chronic bacterial prostatitis is:
  41. To avoid esophageal irritation, patients taking doxycycline (Doryx) for the treatment of epididymitis should be advise to:
  42. Which of the follow is an alpha 1 adrenergic antagonist use to treat benign prostatic hyperplasia?
  43. Doxazosin (Cardura) is an alpha adrenergic antagonist. Oxybutynin (Ditropan), Tolterodine (Detrol) and Solifenacin (Vesicare) are all classified as anticholinergic agents.
  44. Treatment of chronic prostatitis may require prolonged antibiotic regimens, up to:
  45. A 45-year-old man is receive finasteride (Proscar) for the symptomatic treatment of benign prostatic hyperplasia. The patient should be advise that:
  46. A 24-year-old man patient treated for epididymitis cause by Neisseria gonorrhoeae should be advised that:
  47. A common side effect associate with sildenafil (Viagra) is:
  48. Alpha-adrenergic antagonists for the treatment of benign prostatic hyperplasia (BPH):
  49. The generic name for Levitra is:
  50. Patients take tamsulosin (Flomax) should be advise to seek immediate medical attention for:
  51. Concomitant administration of sildenafil (Viagra) and tamsulosin (Flomax) may result in:
  52. The brand name for sildenafil is:
  53. Empiric treatment of epididymitis in a 28-year-old sexually active man is:
  54. Trimethoprim-sulfamethoxazole (Bactrim DS) for the treatment of acute bacterial prostatitis is NOT effective against:
  55. Check out our latest courses on PSYC 502 Week 3.